1. No significant relationship was found be tween blood pressure and blood volume, sulphate space or plasma angiotensin II concentration in 59 non-nephrectomized haemodialysis patients, of whom 42 were hypertensive. Supine mean blood pressure was only weakly correlated with plasma renin activity and the correlation was not improved when blood pressure was related to expressions combining renin and volume.
Introduction
Hypertension in patients established on chronic haemodialysis treatment is normally controlled by dialysis ultrafiltration and by dietary sodium and water restriction (Brown, Dusterdieck, Fräser, Lever, Robertson, Tree & Weir, 1971) . The success of these measures has led to the supposition that the usual cause of hypertension in such patients is sodium and water retention (Blumberg, Nelp, Hegstrom & Scribner, 1967; Brown et al., 1971) , with plasma renin and angiotensin II perhaps inappropriately high for the degree of volume expansion (Rosen & Robinson, 1973; Weidmann, Beretta-Piccoli, Steffen, Blumberg & Reubi, 1976) . Rarely, when sodium and water de pletion do not control arterial pressure, plasma renin may reach very high values with hyper tension then described as 'renin-dependent' (Toussaint, Verniory, Cremer, Vereerstraeten, Kinnaert & van Geertruyden, 1968; Vertes, Cangiano, Berman & Gould, 1969) . However, the demonstra tion that blood pressure can be lowered by sodium and water depletion does not prove that sodium and water retention is the primary cause of the elevated pressure. Nor is it clear to what extent the high renin values observed in some hypertensive dialysis patients may be an appropriate response to chronic sodium and volume depletion. Moreover, high renin values are not confined to those dialysis patients whose blood pressure is raised and have been observed in normotensive patients without evidence of sodium or volume depletion (Weid mann et al, 1976) .
A method of investigating the activity of the renin-angiotensin system, other than that of plasma assays with their inherent difficulties and lack of standardization, is the use of specific in hibitors. The fall in blood pressure in response to saralasin (Sar',Ala 8 -angiotensin II) has been used to assess the contribution of angiotensin II to various forms of hypertension (Streeten, Anderson & Dalakos, 1976) , including the hypertension of chronic renal failure (Liftschitz, Gibney & Kirschenbaum, 1975) . A significant fall in blood pressure during saralasin infusion has been taken as a criterion for bilateral nephrectomy in hyper tensive haemodialysis patients (Liftschitz et al., 1975) , and a failure to respond has been suggested as an indication of volume-dependent hypertension in such patients (Mimran, Deschodt, Polito, Barjon, Mion & Shaldon, 1976) .
The relationship between blood pressure, its response to saralasin, and measurement of plasma renin activity, plasma angiotensin II concentra tion, blood and extracellular fluid volumes are explored in this study of 59 patients with retained diseased kidneys and six anephric patients on regular haemodialysis. The wide variations in body fluid volumes likely to occur in patients without significant renal function make this group an ideal one to examine the ways in which sodium and volume factors affect the response to inhibition of angiotensin II.
Patients and methods
Sixty-five patients (40 male, 25 female), aged 17-55 years (mean 40 years), were studied on the day after a regular haemodialysis treatment. All patients gave informed consent, had been estab lished on haemodialysis for a minimum of 3 months (3-110 months) and were studied whilst on their normal diet and dialysis schedule (Kiil multi point, 4-6 h, 3 times per week). The primary diagnoses were as follows: hypertensive nephrosclerosis, 13 patients (one anephric); chronic glomerulonephritis, 30 patients; chronic pyelone phritis due to reflux, congenital abnormalities of the urinary tract or associated with calculi, 14 patients (four anephric); polycystic disease, five patients; analgesic nephropathy, two patients (one anephric); cortical necrosis, one patient. Forty-two patients were hypertensive, 17 normotensive and six were anephric. Twenty-six patients had pre viously received anti-hypertensive drugs, which were withdrawn at least 7 days before study.
Blood pressure (Arteriosonde) and pulse rate (Harvard 362 crystal transducer) were recorded at 2 min intervals in each study. McGrath, Tiller, Horvath & Johnson, 1976) were measured during a 60 min period of resting supine (control period). Glucose solution (5%) was in fused at 1 ml/min into a forearm vein (with a Sage 355 syringe pump) for the last 20 min of the control period, followed by an infusion of saralasin (in 5% glucose solution at the same rate) at 10 nmol min -1 kg -1 and then 5-2 nmol min -1 kg -1 , each for 20 min. Finally, the patient stood for a 10 min period, during which time the saralasin in fusion (5-2 nmol min -1 kg -1 ) was continued. Blood samples for measurement of plasma renin activity (PRA) (Sealey & Laragh, 1975) and angiotensin II (Ruiz-Maza, Tiller & Walker, 1974) were taken at the end of the supine control period and PRA was measured again at the end of the saralasin infusion in the supine position.
A more detailed study was performed in 13 patients (all with kidneys) after 5 days on each of two diets: high sodium (100 mmol/day) and low sodium (<20 mmol/day). On the low sodium diet, volume replacement during dialysis was made with 5% glucose in water instead of sodium chloride solution (150 mmol/1). The sodium concentration of the dialysis fluid was constant for each patient. In these patients the effects of tilt alone (40° headup for 20 min) were assessed after 60 min supine followed by a post-tilt 30 min supine recovery period and then by saralasin infusion over three consecutive 20 min periods (1-0 nmol min -1 kg -1 , supine, 10-5 nmol min -1 kg -' supine and 10-5 nmol min^1 kg -1 with tilt). PRA was measured at the end of each phase.
Supine systolic, diastolic and mean (diastolic +j pulse pressure) blood pressure and pulse rate readings were averaged over the last 20 min of control observations and for the 20 min of the higher dose saralasin infusion (5-2 or 10-5 nmol min -1 kg -1 ). Average blood pressures and pulse rates for standing and tilt studies were also compared with average control observations. An initial transient pressor response was frequently observed at the beginning of saralasin infusion (McGrath, Ledingham & Benedict, 1977) .
Blood volume was calculated from plasma volume and peripheral packed cell volume, with a correction factor of 0-915 for total body packed cell volume (PC V). This was the mean value for the ratio total body PC V/peripheral PCV obtained in a preliminary study of 23 dialysis patients in whom simultaneous measurements were made of plasma volume ( 125 I-labelled albumin), erythrocyte mass ( lsl Cr-labelled erythrocytes) and peripheral venous packed cell volume (B. P. McGrath, unpublished observations). Blood volume measurements were related to height and expressed as % of normal to allow for sex differences (Tarazi, Dustan, Fröhlich, Gifford & Hoffman, 1970) . Sulphate space was expressed as 1/m 2 of body surface area and as 1/cm -3 height. Statistical methods employed were the paired ttest and linear and multiple regression analysis (Snedecor & Cochrane, 1969) .
Results

Relationships between blood pressure, blood volume and PRA
No significant relationship was found between blood pressure (supine or standing) and blood volume or sulphate space (Table 1) . A weak correlation was observed between supine mean blood pressure and PRA (r = 0-22, Ρ<0·05). However, this relationship was not significantly strengthened by substituting for PRA any of the renin x volume computations shown in Table 2 .
A significant inverse correlation was found between blood volume and PRA (r = -0-43, /'<0·001) and also between sulphate space and PRA (r = -0-42, .Ρ<0·001). No difference was discernible in these renin-volume plots between hypertensive (supine mean blood pressure >110 mmHg, « = 42) and normotensive (supine mean blood pressure <110 mmHg, n = 17) patients (Fig.  1 ).
Blood pressure response to saralasin
All six anephric patients and 25 of the 59 nonnephrectomized patients showed a modest and sustained increase in mean blood pressure during saralasin infusion. The change in mean blood pressure during saralasin infusion was significantly and inversely related to pre-infusion PRA and angiotensin II values (Fig. 2) and directly related to blood volume (r = 0-50, i><0-001; Fig. 3 ) and sul phate space measurements (r = 0·47, P<0001) in the non-nephrectomized group. The change in PRA induced by saralasin was significantly and inversely correlated with the blood pressure res ponse (r = -0-60, P<0001).
In only 12 patients (one normotensive) was the fall in mean blood pressure during saralasin in fusion greater than 10% of the control value. As shown in Fig. 1 , these patients had not only the highest PRA values but also the lowest blood volume measurements. Multiple regression analysis suggested that blood volume was exerting an influ ence on the blood pressure response to saralasin which was independent of this relationship between renin and volume (F = 5-5, Ρ<0·05).
The changes in mean blood pressure induced by saralasin infusion were not significantly different between the upright and the supine positions (-6-9 ± SEM 1-8 mmHg vs -4-2 ± SEM 1-6 mmHg; P> 0-10).
Effects of dietary sodium manipulation
Changes in dietary sodium in 13 patients (nine hypertensive, four normotensive) resulted in signifi cant changes in body weight, plasma sodium, plasma volume, packed cell volume and sulphate space (Table 3) . When the data from the two dietary periods were compared, mean PRA was higher after the low sodium diet but the difference was not significant {P >0· 1).
In the nine hypertensive patients in whom salt restriction was associated with significant falls in volume and weight, supine mean blood pressure was significantly higher on the low sodium diet (132 ± 4 vs 126 ± 3 mmHg, P <002). In these hypertensive patients saralasin lowered mean blood pressure in the supine (/> <0-001) and tilt (P<002) positions on the low sodium diet, but only in the tilt position on the high sodium diet (P <0-02). The four normotensive patients had a slight fall in tilt mean blood pressure during saralasin infusion on the low sodium diet (Table 4) ) and blood volume (related to height and expressed as % of normal) for 59 non-nephrectomized haemo dialysis patients. O, Supine 'control' MBP <110 mmHg; · , supine 'control' > 110 mmHg; r = 0-50, P <0·001.
Relationship of PRA to plasma sodium and potassium concentrations
Plasma renin activity was found to be inversely related to both plasma sodium (r = -0-28, n = 72, P <0·01) and plasma potassium concentrations (r = -0-39, « = 72, P <0·01) in the dialysis patients with kidneys. The plasma sodium and potassium concentrations were not significantly related to one another.
Discussion
The lack of any significant relationship between blood pressure and blood volume or extracellular fluid volume (sulphate space) measurements in non-nephrectomized haemodialysis patients is in agreement with the findings of Dathan, Johnson & Goodwin (1973) and Weidmann et al. (1976) . Moreover in the nine hypertensive patients studied at two levels of dietary sodium intake, supine mean blood pressure was lower on the high salt intake, despite the higher volumes induced by that diet (Tables 3 and 4) . These results are surprising in view of the widespread belief that hypertension in the majority of patients requiring regular haemodialysis is 'volume dependent' (Blumberg et al., 1967; Vertes et al., 1969; Brown et al., 1971) . Although Brown, Curtis, Lever, Robertson, de Wardener & Wing (1969) and Wilkinson, Scott, Uldall, Kerr & Swinney (1970) found a correlation between plasma renin concentration and blood pressure in dialysed patients, others have not con firmed this (Zech, Sassard, Moskovtchenko, Pozet & Traeger, 1968; Craswell, Hird, Judd, Baillod, Varghese & Moorhead, 1972) . In these early studies the effects of the wide variations in body fluid volumes characteristic of dialysed patients were not examined. Various methods of taking account of the effects of volume changes on renin activity have since been employed. Rosen & Robinson (1973) have suggested estimating 'effective' renin by calculating the product of exchangeable sodium and the logarithm of plasma renin concentration and noted a significant relationship between 'effective' renin and blood pressure in a group of patients on haemodialysis. In a similar manner Weidmann et al. (1976) cal culated 'sodium-renin' and 'volume-renin' pro ducts and found significant relationships between supine mean blood pressure and both products. In contrast, we have found only a weak correlation between supine mean blood pressure and the product of sulphate space (1/cm -3 height) and log PRA, and no relationship between blood pressure and the product of blood volume and log PRA (Table 2) . Although we have not measured ex changeable sodium in this study, there is a close relationship between exchangeable sodium and sul phate space in haemodialysis patients (McGrath et al., 1976 ) and therefore we have no reason to suspect that any 'sodium-renin' product would have greater discriminatory value than the 'sul phate space-renin' product.
As shown in Fig. 1 , and from previous studies (Warren & Ferris, 1970; Weidmann et al., 1976) , it is clear that many dialysis patients have PRA values which are not appropriately suppressed despite evidence of volume expansion. However, the significance of this observation in relation to the cause of the raised blood pressure is uncertain since inappropriately high renin values were observed in normotensive as well as hypertensive patients.
Factors other than volume changes may also influence renin values in patients with chronic renal failure. The inverse relationship between PRA and plasma sodium concentration observed in the nonnephrectomized haemodialysis patients in this study has been observed previously in a variety of hypertensive states with and without renal failure (Brown, Davies, Lever & Robertson, 1965; Toussaint et al., 1969) . Potassium balance also influence plasma renin values in normal subjects and hypertensive patients without renal failure (Brunner, Baer, Sealey, Ledingham & Laragh, 1970) . The inverse relationship between PRA and plasma potassium concentration observed in this study suggests that changes in potassium balance may also affect renin values in dialysed patients.
Saralasin infusion was used in this study to explore the possibility that 'angiotensin-dependent' hypertension may not be revealed by determina tion of venous plasma renin and angiotensin II values. The close relationship between the blood pressure response to saralasin infusion and preinfusion values of plasma renin or angiotensin II seen in haemodialysis patients (Fig. 2) has been observed in other forms of hyper tension (Case, Wallace, Keim, Sealey & Laragh, 1976; Geyskes, Vos, Boer & Dorhoot Mees, 1976) and confirms that in patients with high values for circulating renin and angiotensin II, the reninangiotensin system is playing some part in main taining the elevated blood pressure. However, it does not support the existence of occult 'angio tensin-dependent' hypertension in patients in whom renin and angiotensin II values are not raised. Moreover, a marked fall in blood pressure in response to saralasin does not differentiate between a primary over-production of renin or an appropri ate response to volume depletion. Conversely an in significant response, or a rise in pressure, may be observed in the presence of volume expansion (Streeten et al., 1976; Case et al., 1976; Geyskes et al., 1976; Donker & Leenen, 1974) . The possibility that longer maintained infusions of saralasin might have decreased arterial pressure when shorter ones did not was not explored. Multiple regression analysis of our results in 59 non-nephrectomized patients suggested a possible influence of volume on the blood pressure response to saralasin which appeared to be independent of the effects of volume changes on the renin-angiotensin system.
There are other limitations to saralasin. It possesses significant agonist activity (Case et al., 1976) , which is more pronounced in the sodiumand volume-repleted state (Streeten et al., 1976; Case et al., 1976; Donker & Leenen, 1974) and when plasma renin values are low (Case et al., 1976) . Furthermore, a rise in plasma noradrenaline concentration has been observed during saralasin infusion (McGrath et al., 1977; Röckel, Heidland, Appel & Palm, 1977) , which suggests that the antagonist may have some angiotensin II like actions on the central or peripheral autonomic nervous system or on the adrenal medulla as well as vascular receptors.
Posture may also influence the response to saralasin, as shown by the fall in tilt mean blood pressure induced by the antagonist in nine sodiumreplete hypertensive dialysis patients in whom no such fall was observed when supine (Table 4 ).
These observations suggest that the blood pressure response to saralasin may be a useful and rapid estimate of the amount of circulating angio tensin II, but does not help to clarify the possible importance of the renin-angiotensin system in the pathogenesis of hypertension in patients under going regular haemodialysis. Although a signifi cant fall in blood pressure occurred in patients with very high PRA and angiotensin II values (Fig. 2) , such a response was observed in normotensive as well as hypertensive patients and was most pronounced in those patients with evidence of volume depletion ( Fig. 1 and Fig. 3) .
The analysis of blood pressure, PRA, plasma angiotensin II and volume measurements presented in this study does not exclude contributions from both the renin-angiotensin system and sodium retention to the hypertension of end-stage renal disease. Even so, others have also failed to find a satisfactory explanation of hypertension in dialysed patients from inappropriate activity of the reninangiotensin system and/or sodium retention with volume expansion (Cannella, Castellani, Mioni, Usberti, Guerra, Albertini & Maiorca, 1977) . There is increasing evidence of disturbed antonomic function in some of these patients (Lilley, Golden & Stone, 1976; Atuk, Westervelt & Peach, 1975) , a disorder which may contribute to hyper tension more than has hitherto been recognized (McGrath, Tiller, Bune, Chalmers, Körner & Uther, 1977) . 
